News - Posidur, Durect

Filter

Current filters:

PosidurDurect

Popular Filters

US FDA accepts DURECT's NDA for Posidur

20-06-2013

DURECT Corp (Nasdaq: DRRX) says that the New Drug Application for its investigational product Posidur…

DurectNeurologicalNorth AmericaPharmaceuticalPosidurRegulation

Hospira returns Posidur rights to DURECT

02-04-2012

DURECT Corp (Nasdaq: DRRX) says that fellow USA-based that Hospira (NYSE: HSP) has given notice that…

DurectHospiraLicensingNeurologicalNorth AmericaPharmaceuticalPosidur

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top